The KPK received the report about alleged graft from the Financial Transaction Analysis and Reporting Center (PPATK).
"As for the PPATK report about a pharmaceutical company involved in graft case, is yet to be analyzed and looked into. KPK received many reports from PPATK. We cant just charge anyone right away. We need time to determine if the is a case or not ," acting head of the KPK public relation bureau Yuyuk Andriati said here on Friday.
Yuyuk referred to a statement by KPK chairman Agus Rahardjo that KPK had received a report from PPATK on fantastic graft money received by medical doctors.
"A few days ago I received a report from PPATK that a not very big pharmaceutical company had transferred Rp800 billion to a number of doctors over the past three years," Agus said on Thursday.
Yuyuk said KPK apart from fighting corruption and arrested perpetrators also has to launch program to prevent corruption.
KPK has to cooperate with the health ministry to prevent such graft.
There will be regulation on sponsorship about doctors, Yuyuk said, adding currently a system is being prepared in cooperation between KPK and the health ministry.
"Momentum of prevention could be created, but most important is whether KPK has found evidence to charge a suspect," she said.
She said KPK believed not only a company has given graft money to doctors, adding "we are still analyzing the case, and could not given details."
KPK, however, has the authority to deal against civil servant doctors in such graft case.(*)
Editor: Heru Purwanto
Copyright © ANTARA 2016
